DR. ODELIA COOPER, M.D.
Osteopathic Medicine in Los Angeles, CA
License number
California A88399
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
License number
California A88399
Category
Osteopathic Medicine
Type
Hypertension Specialist
Address
Address
8723 Alden Dr. Ssb-290, Los Angeles, CA 90048
Phone
(310) 423-3870
(310) 423-0429 (Fax)
(310) 423-4774
(310) 423-0440 (Fax)
(310) 423-0429 (Fax)
(310) 423-4774
(310) 423-0440 (Fax)
Personal information
See more information about ODELIA COOPER at radaris.comName
Address
Phone
535 N Vista St, Los Angeles, CA 90036
1472 Canfield Ave, Los Angeles, CA 90035
535 Vista St, Los Angeles, CA 90036
Organization information
See more information about ODELIA COOPER at bizstanding.comOdelia Cooper MD
8700 Beverly Blvd, Los Angeles, CA 90048
Industry:
Internist
Phone:
(310) 423-2830 (Phone)
Odelia Bracha Cooper
Professional information
See more information about ODELIA COOPER at trustoria.com
Physician At Cedars-Sinai Medical Center
Physician At Cedars-Sinai Medical Center
Position:
Physician at Cedars-Sinai Medical Center
Location:
Greater Los Angeles Area
Industry:
Medical Practice
Work:
Cedars-Sinai Medical Center
-
Physician
Education:
Yeshiva University High School of Los Angeles 1989 - 1993
The Johns Hopkins University
The Johns Hopkins University
Odelia Bracha Cooper, West Hollywood CA
Odelia Bracha Cooper, West Hollywood CA
Specialties:
Internist
Address:
8700 Beverly Blvd, West Hollywood, CA 90048
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Odelia Bracha Cooper, West Hollywood CA
Odelia Bracha Cooper, West Hollywood CA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
8700 Beverly Blvd, Los Angeles, CA 90048
Education:
Johns Hopkins University (2002)
Dr. Odelia Cooper, Los Angeles CA - MD (Doctor of Medicine)
Dr. Odelia Cooper, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
Cedars-Sinai Med Ctr END/RHU
8723 Alden Dr SUITE 298, Los Angeles 90048
(310) 423-3870 (Phone)
Cedar-Sinai Med Ctr Ptutry Ctr
127 San Vicente Blvd SUITE A6600, West Hollywood 90048
(310) 423-2830 (Phone)
8723 Alden Dr SUITE 298, Los Angeles 90048
(310) 423-3870 (Phone)
Cedar-Sinai Med Ctr Ptutry Ctr
127 San Vicente Blvd SUITE A6600, West Hollywood 90048
(310) 423-2830 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2008, Internal Medicine, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Cedars-Sinai Med Ctr END/RHU
8723 Alden Dr SUITE 298, Los Angeles 90048
Cedar-Sinai Med Ctr Ptutry Ctr
127 San Vicente Blvd SUITE A6600, West Hollywood 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
8723 Alden Dr SUITE 298, Los Angeles 90048
Cedar-Sinai Med Ctr Ptutry Ctr
127 San Vicente Blvd SUITE A6600, West Hollywood 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 2002
Johns Hopkins University / School of Medicine
Graduated: 2002
Use Of Tyrosine Kinase Inhibitors For Treatment Of Prolactinoma
Use Of Tyrosine Kinase Inhibitors For Treatment Of Prolactinoma
US Patent:
2012030, Dec 6, 2012
Filed:
Jan 31, 2011
Appl. No.:
13/576564
Inventors:
Hidenori Fukuoka - Culver City CA, US
Odelia Cooper - Los Angeles CA, US
Shlomo Melmed - Los Angeles CA, US
Odelia Cooper - Los Angeles CA, US
Shlomo Melmed - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 31/517, A61K 39/395, C12Q 1/48, A61K 31/713, A61K 31/5377, A61K 38/16, A61K 31/7088
US Classification:
4241351, 514 192, 4241721, 514 44 R, 51426624, 4241331, 514 44 A, 5142345, 435 15
Abstract:
The invention relates to methods and kits for the treatment of prevention of and lowering the chances of developing prolactinomas by the administration of a tyrosine kinase inhibitor, such as lapatinib.